📋 Tender Overview
Scope : To Develop a Pharmaceutical and Biotechnology (Biotech) Hub in Malaysia.
Meta Bright Group Bhd has signed a memorandum of understanding (MOU) with ChemPartner Pharmatech Co Ltd to develop a pharmaceutical and biotechnology (biotech) hub in Malaysia.
The hub would focus on research and development, manufacturing, and commercialisation of pharmaceutical products and biotech advancements.
This initiative represents a pioneering collaboration with ChemPartner, a leading Chinese-listed company, to establish such a hub in Malaysia.
ChemPartner, a listed company on the Shenzhen Stock Exchange with a market capitalisation of approximately RM1.6 billion, is renowned for offering comprehensive, integrated services, including discovery chemistry, biology, pharmacology, drug metabolism and pharmacokinetics, and toxicology.
Under the MOU, Meta Bright will identify a strategic site for establishing the hub, and oversee the construction and development of laboratories, manufacturing facilities, and office/retail spaces.
Additionally, Meta Bright is committed to implementing environmentally sustainable practices to minimise ecological impact and promote green initiatives.
ChemPartner will seek and facilitate investment opportunities to support the hub’s growth, engaging with China’s pharmaceutical and biotech companies, academic institutions, and research organisations to foster collaboration.
This project would differentiate the company from typical developments, as it involves creating a niche market with a leader in the pharmaceutical and biotech sectors.
Partner :
ChemPartner Pharmatech Co Ltd
Address : 1F & 3F, Block A, 2829 JinKe Road, Zhangjiang Hi-Tech Park, PuDong New Area, Shanghai, China 201203
Tel: +86 21 5132 0088
Email : contact@chempartner.com
Website : https://chempartner.com/
